4.4 Article

PKM2 and cancer: The function of PKM2 beyond glycolysis

Journal

ONCOLOGY LETTERS
Volume 11, Issue 3, Pages 1980-1986

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2016.4168

Keywords

PKM2; glycolysis; cancer; metabolic reprogramming; Warburg effect; novel function

Categories

Funding

  1. Natural Science Foundation of Jiangsu Province [BK2012482]
  2. National Natural Science Foundation of China [81472702]
  3. Jiangsu Province Special Program of Medical Science [BL2012030]

Ask authors/readers for more resources

Metabolic reprogramming is a hallmark of cancer cells and is used by cancer cells for growth and survival. Pyruvate kinase muscle isozyme M2 (PKM2) is a limiting glycolytic enzyme that catalyzes the final step in glycolysis, which is key in tumor metabolism and growth. The present review discusses the expression and regulation of PKM2, and reports the dominant role that PKM2 plays in glycolysis to achieve the nutrient demands of cancer cell proliferation. In addition, the present study discusses the non-metabolic function of PKM2, and its role as a coactivator and protein kinase, which contributes to tumorigenesis. Furthermore, conflicting studies concerning the role of PKM2 as a therapeutic target are reviewed. The improved understanding of PKM2 may provide a noval approach for cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available